therapeut
applic
sirna
show
promis
altern
approach
small
molecul
inhibitor
treatment
human
diseas
howev
major
obstacl
use
difficulti
deliv
larg
anion
molecul
vivo
studi
investig
whether
sirnamedi
knockdown
map
kinas
mrna
mous
lung
influenc
conjug
nonvir
deliveri
vector
cholesterol
cell
penetr
peptid
cpp
tat
penetratin
initi
studi
mous
fibroblast
cell
line
show
sirna
conjug
cholesterol
tat
penetratin
sirna
alon
achiev
limit
reduct
map
kinas
mrna
express
intratrach
administr
sirna
result
localis
within
macrophag
scatter
epitheli
cell
produc
knockdown
map
kinas
mrna
increas
dose
sirna
conjug
cholesterol
improv
upon
durat
magnitud
mrna
knockdown
whilst
penetratin
tat
effect
importantli
administr
penetratin
tat
peptid
alon
caus
signific
reduct
map
kinas
mrna
express
whilst
penetratinsirna
conjug
activ
innat
immun
respons
overal
studi
suggest
conjug
cholesterol
may
extend
increas
sirna
mediat
cpp
cholesterolsirna
conjug
mous
lung
support
inform
avail
figur
dosedepend
percentil
map
kinas
mrna
level
vitro
follow
lipofect
three
mous
map
kinas
sirna
two
mismatch
control
figur
analyt
hplc
electrospray
mass
spectrogram
peptideand
cholesterylrna
construct
figur
analyt
gel
cpp
cholesterol
conjug
anneal
product
figur
cell
viabil
follow
incub
sirna
cpp
sirna
conjug
figur
map
kinas
express
across
mous
tissu
panel
inform
avail
free
charg
via
internet
map
kinas
mrna
knockdown
lung
furthermor
use
cpp
may
limit
due
yet
uncharacter
effect
upon
gene
express
potenti
immun
activ
discoveri
rna
interfer
rnai
applic
short
interfer
rna
sirna
knockdown
protein
express
mrna
degrad
revolutionis
area
function
genom
thu
sirna
macromolecul
compos
doubl
strand
rna
nucleotid
length
commonli
use
cell
base
studi
investig
gene
function
furthermor
number
academ
group
biotechnolog
compani
investig
util
sirna
therapeut
approach
treatment
diseas
macular
degener
hepat
c
infect
cancer
compar
small
molecul
inhibitor
rel
larg
size
anion
charg
sirna
mean
one
key
barrier
vivo
use
avail
effect
approach
deliveri
specif
tissu
across
plasma
membran
sinc
intraven
sirna
administr
subject
firstpass
metabol
unless
liver
condit
target
ie
hepat
c
infect
therapeut
applic
limit
tissu
sirna
localis
extend
period
possibl
eg
follow
intraocular
inject
treatment
macular
degener
case
lung
structur
tissu
permit
direct
access
larg
number
cell
within
branch
airway
alveoli
estim
surfac
area
man
importantli
facil
topic
deliveri
via
either
intranas
intratrach
aerosol
administr
suggest
lung
ideal
target
organ
sirnabas
therapeut
inde
studi
shown
sirnamedi
attenu
cytokin
heme
induc
express
acut
lung
injuri
similarli
intranas
intratrach
sirna
administr
shown
prevent
parainfluenza
respiratori
syncyti
viru
piv
rsv
respect
infect
mice
sever
acut
respiratori
syndrom
sar
infect
rhesu
monkey
major
studi
cation
lipid
eg
lipofectin
polym
eg
pei
dendrim
employ
packag
deliv
sirna
lung
howev
gener
applic
strategi
limit
drawback
toxic
sirnamedi
induct
immun
respons
toll
like
receptor
tlr
attempt
circumv
problem
examin
util
chemic
conjug
sirna
nonvir
deliveri
vector
cholesterol
cell
penetr
peptid
cpp
penetratin
tat
improv
sirna
mediat
mrna
knockdown
mous
lung
specif
attempt
target
constitut
express
mitogen
activ
protein
map
kinas
also
known
activ
protein
known
import
releas
multipl
proinflammatori
mediat
includ
tumour
necrosi
factor
tnf
interleukin
il
inde
mani
pharmaceut
compani
develop
small
molecul
inhibitor
target
map
kinas
use
treatment
host
inflammatori
diseas
includ
rheumatoid
arthriti
crohn
diseas
chronic
obstruct
pulmonari
diseas
psoriasi
cholesterol
conjug
sirna
shown
silenc
endogen
apolipoprotein
b
apob
gene
express
liver
jejunum
result
decreas
plasma
level
apob
protein
total
cholesterol
interestingli
recent
studi
shown
deliveri
sirna
target
apob
increas
compar
cholesterol
conjug
formul
stabilis
nucleic
acid
lipid
particl
snalp
addit
evid
util
cholesterol
oligonucleotid
deliveri
provid
recent
report
show
cholesterolmedi
deliveri
phosphorothioatemodifi
singl
strand
rna
knockdown
microrna
express
liver
lung
kidney
heart
intestin
fat
skin
bone
marrow
muscl
ovari
adren
gland
follow
intraven
inject
cpp
tat
penetratin
short
cation
peptid
deriv
tat
transactiv
protein
insect
antennaedia
homeoprotein
extens
use
vitro
vivo
deliveri
biolog
activ
peptid
protein
significantli
cpp
shown
mediat
uptak
rang
biolog
nonbiolog
cargo
led
suggest
may
repres
univers
nontox
approach
deliveri
oligonucleotid
interestingli
although
studi
examin
util
cpp
vivo
deliveri
sirna
possibl
support
report
show
penetratin
mediat
deliveri
sirna
antisens
isol
neuron
tat
sirna
conjug
mediat
knockdown
egfp
express
hela
cell
report
demonstr
intratrach
administr
sirna
achiev
limit
attenu
mrna
express
lung
endogen
constitut
express
target
map
kinas
howev
although
conjug
cholesterol
tat
penetratin
facilit
knockdown
map
kinas
mrna
mous
cell
line
cholesterolsirna
conjug
found
influenc
target
gene
mrna
level
vivo
importantli
sinc
cpp
inhibit
map
kinas
mrna
express
vivo
vitro
document
exist
yet
uncharacteris
cpp
bioactiv
moreov
detect
innat
immun
respons
induct
penetratinsirna
tat
sirna
conjug
suggest
differenti
cellular
uptak
mechan
two
cpp
sirna
conjug
annealinginiti
screen
studi
perform
preanneal
page
purifi
sirna
obtain
dharmacon
inc
lafayett
usa
use
follow
sequenc
sens
antisens
b
sens
antisens
c
sens
antisens
mismatch
sens
antisens
mismatch
sens
antisens
synthesi
disulphid
link
construct
perform
dr
brian
sproat
integr
dna
technolog
leuven
belgium
npi
activ
ctermin
cy
contain
tat
grkkrrqrrrppqc
penetratin
rqikiwfqnrrmkwkkc
peptid
ntermin
acetyl
ctermin
amid
function
obtain
american
peptid
compani
inc
sunnyval
usa
conjug
sens
strand
sequenc
c
hs
ch
op
gggaggugcccgaacgauauidt
via
disulfid
exchang
denatur
condit
presenc
urea
two
peptiderna
conjug
purifi
prepar
anionexchang
hplc
denatur
condit
desalt
suppli
lyophil
sodium
salt
puriti
final
product
determin
analyt
anionexchang
hplc
electrospray
mass
spectroscopi
deconvolut
analyt
hplc
construct
elut
monoq
column
amersham
bioscienc
piscataway
nj
usa
linear
gradient
buffer
b
buffer
ab
flow
rate
mlmin
effluent
monitor
uv
spectroscopi
hs
ch
op
gggaggugcccgaacgauauidt
analyt
hplc
buffer
consist
liclo
trishcl
edta
urea
ph
buffer
b
buffer
liclo
penetratin
tat
peptiderna
conjug
liclo
substitut
nacl
buffer
b
respect
chol
ch
ss
ch
op
ogggaggugcccgaacgauauidt
linear
gradient
buffer
b
ab
elut
mlmin
use
buffer
prepar
vv
acetonatril
ph
absenc
urea
nacl
buffer
b
respect
cholesterol
conjug
sens
strand
rna
synthes
directli
solid
phase
use
commerci
avail
cholesterol
phosphoramidit
coupl
linker
rna
mismatch
studi
anim
perform
ncoch
ch
op
antisens
anneal
lyophil
sirnasens
strand
sens
strand
conjug
resuspend
concentr
steril
dublecco
phosphat
buffer
salin
pb
sigma
pool
uk
mix
pipet
equal
volum
antisens
strand
resuspend
pb
equimolar
concentr
give
final
sirna
concentr
anneal
perform
heat
min
peltier
element
thermal
cycler
block
follow
slow
cool
period
sirna
construct
analysi
qualiti
controlann
product
examin
upon
precast
polyacrylamid
tri
borat
ethylenedinitrilotetraacet
acid
edta
gel
invitrogen
carlsbad
usa
rna
visualis
sybrgold
stain
recommend
manufactur
invitrogen
document
use
computercontrol
uvp
geldocit
imagin
system
fisher
fit
ethidium
bromid
filter
imag
analysi
perform
use
uvp
imag
acquisit
analysi
softwar
version
media
cybernet
inc
atlanta
ga
usa
lp
content
dose
prepar
determin
use
pyrogen
recombin
factor
c
endotoxin
detect
system
accord
manufactur
instruct
cambrex
bio
scienc
wokingham
ltd
wokingham
uk
assess
sirna
sirna
conjug
suscept
rnase
simul
lung
microenviron
stabil
studi
carri
murin
bronchoalveolar
lavag
bal
fluid
collect
three
termin
anaesthet
male
balbc
mice
follow
exposur
lung
three
repeat
lavag
rpmi
media
invitrogen
collect
media
pool
store
assess
sirna
stabil
bal
fluid
anneal
sirna
sirna
construct
incub
excess
volum
vv
murin
bal
fluid
ul
volum
remov
set
timepoint
gel
load
buffer
ii
invitrogen
quickli
ad
final
concentr
mixtur
snap
frozen
liquid
nitrogen
sampl
thaw
ice
pmol
quantiti
analys
polyacrylamid
gel
electrophoresi
page
vitro
cell
cultur
cell
grown
confluenc
dmem
sigma
supplement
foetal
calf
serum
penicillinstrepavidinglutamin
mm
nonessenti
amino
acid
invitrogen
day
transfect
cell
trypsinis
resuspend
media
sirna
sirnalipofectamin
invitrogen
complex
prepar
manufactur
instruct
sirnaconjug
dilut
final
indic
concentr
optimem
invitrogen
mix
equal
volum
cell
suspens
give
final
serum
concentr
fc
cell
plate
plate
triplic
volum
cell
well
incub
either
rna
extract
measur
cell
viabil
use
mtt
assay
sigma
carri
vivo
proceduresal
vivo
procedur
carri
local
ethic
approv
strict
accord
anim
scientif
procedur
act
group
male
balbc
mice
sedat
halothan
given
indic
dose
sirna
mismatch
sirna
conjug
tat
penetratin
polyinosin
polycytidyl
acid
poli
c
sigma
lp
escherichia
coli
sigma
volum
intratrach
administr
anim
sacrif
indic
timepoint
use
overdos
pentobarbiton
intraperiton
cultur
sampl
extract
use
qiagen
rneasi
mini
kit
accord
manufactur
instruct
qiagen
crawley
uk
anim
tissu
gentli
remov
immedi
confirm
death
store
either
rnalat
accord
manufactur
instruct
sigma
total
rna
extract
rotorst
homogenis
tri
reagent
sigma
use
ultraturrax
homogen
follow
isopropanol
precipit
aqueou
phase
reconstitut
rnasefre
water
promega
southampton
uk
yield
puriti
determin
spectrophotometr
measur
absorb
determin
map
kinas
mrna
express
mousespecif
taqman
primer
probe
obtain
assay
demand
servic
provid
appli
biosystem
assay
appli
biosystem
applera
corp
warrington
uk
realtim
pcr
perform
use
onestep
quantitect
rtpcr
kit
qiagen
microamp
reaction
plate
appli
biosystem
well
contain
ng
total
rna
nm
forward
revers
transcript
primer
nm
taqman
probe
reaction
volum
sampl
nontempl
control
reaction
perform
abi
prism
sequenc
detect
system
appli
biosystem
triplic
compar
slope
relationship
log
rna
ct
gradient
gene
interest
endogen
control
appli
biosystem
indic
compar
ct
method
could
use
rel
quantif
gene
express
data
analys
prism
version
statist
analysi
packag
graphpad
softwar
inc
san
diego
ca
usa
use
nonparametr
analysi
varianc
follow
tukey
posttest
appropri
measur
cytokin
protein
expressionlung
gentli
remov
immedi
confirm
death
snap
frozen
liquid
nitrogen
store
frozen
lung
homogenis
icecold
ripa
buffer
aprotinin
ml
leupeptin
pepstatin
mm
dithithreitol
mm
phenylmethylsulphonyl
fluorid
mm
sodium
orthovanad
mm
sodium
fluorid
mm
sodium
pyrophosph
sigma
ratio
ml
per
mg
tissu
use
ultraturrax
homogen
fisher
scientif
homogen
spun
refriger
tabletop
microcentrifug
g
min
supernat
remov
store
total
protein
content
determin
bradford
assay
biorad
hertfordshir
uk
accord
manufactur
instruct
tissu
tumour
necrosi
factor
tnf
interleukin
il
duoset
elisa
kit
r
system
europ
abingdon
uk
interferon
ifn
pbl
laboratori
piscataway
nj
usa
measur
sandwich
elisa
normalis
total
protein
content
end
label
antisens
strand
dharmacon
anneal
appropri
sens
strand
result
label
sirna
penetratinsirna
tatsirna
cholesterolsirna
equimolar
amount
alon
given
intratrach
administr
whole
lung
collect
hour
later
fix
formaldehydesuppl
phosphat
buffer
salin
sigma
fixat
sampl
rins
etoh
dehydr
embed
paraffin
paraffin
section
leica
microtom
leica
microsystem
milton
keyn
uk
rehydr
rins
trisbuff
sali
ph
sigma
stain
dnabind
fluorochrom
hoechst
sigma
mount
aqua
perm
mountant
life
sci
intern
red
channel
hoechst
green
channel
visual
epifluoros
microscop
olympu
olympu
sveridg
ab
solna
sweden
equip
high
resolut
olympu
digit
camera
olympu
sveridg
ab
link
computer
imag
analysi
system
viewfind
lite
pixera
co
imagepro
plu
v
media
cybernet
posit
cell
phenotyp
lung
parenchyma
alveolar
macrophag
distinguish
structur
alveolar
cell
immunohistochem
visual
macrophag
marker
briefli
rehydr
slide
subject
antigen
retriev
mild
proteinas
k
digest
sigma
block
nonspecif
bind
site
section
incub
monoclon
rat
antimurin
dilut
clone
ci
serotec
ltd
oxford
uk
repeat
rins
immunoreact
detect
alexa
conjug
goat
anti
rat
antibodi
green
channel
tat
penetratin
cholesterolmedi
sirna
knockdown
map
kinas
mrna
mous
cell
lineiniti
studi
focus
upon
identif
optimum
sirna
sequenc
map
kinas
mrna
knockdown
end
concentr
depend
knockdown
achiev
three
sirna
determin
mous
fibroblast
cell
line
hr
figur
follow
revers
transfect
lipofectamin
thu
efficaci
sequenc
c
select
gave
maxim
knockdown
ec
transfect
cell
lipofectamin
figur
neg
control
identifi
mismatch
sirna
sequenc
gave
signific
knockdown
except
highest
concentr
observ
map
kinas
mrna
reduct
figur
facilit
conjug
tat
penetratin
cholesterol
upon
sirna
end
sirna
sens
strand
modifi
linker
provid
thiol
group
disulphid
conjug
cystein
residu
cpp
analyt
hplc
electrospray
mass
spectrogram
avail
figur
linker
modifi
sens
strand
cppsens
strand
conjug
anneal
antisens
strand
yield
sirna
duplex
evalu
impact
conjug
linker
group
biolog
action
sirna
modifi
sirna
duplex
transfect
use
lipofectamin
cultur
fibroblast
addit
linker
sirna
signific
effect
upon
magnitud
knockdown
caus
shift
ec
figur
visual
examin
cppsirna
construct
show
precipit
whilst
separ
polyacrylamid
gel
demonstr
format
discret
anneal
product
figur
contrast
anneal
cholesterolsirna
gave
higher
molecular
weight
product
suggest
format
higher
order
structur
biolog
action
sirna
conjug
tat
penetratin
cholesterol
examin
vitro
follow
incub
absenc
transfect
reagent
ie
lipofectamin
figur
show
equimolar
concentr
sirna
incub
absenc
lipofectamin
tat
peptid
penetratin
peptid
effect
upon
map
kinas
mrna
level
contrast
tat
penetratinand
cholesterolsirna
conjug
produc
small
signific
knockdown
respect
figur
examin
construct
show
signific
cellular
toxic
figur
sirnamedi
mrna
knockdown
map
kinas
mous
lungexamin
rel
level
map
kinas
express
mous
tissu
indic
constitut
express
lung
figur
ascertain
capac
sirna
downregul
map
kinas
mrna
level
increas
dose
linker
modifi
sirna
administ
intratrach
effect
upon
map
kinas
mrna
express
determin
period
figur
seen
dose
linkermodifi
sirna
sirna
produc
signific
mrna
knockdown
howev
effect
appear
transient
anim
dose
show
significantli
attenu
gene
express
administr
mismatch
control
produc
signific
downregul
map
kinas
express
period
figur
effect
conjug
tat
penetratin
cholesterol
upon
sirnamedi
mrna
knockdown
map
kinas
mous
lungw
next
investig
whether
durat
magnitud
map
kinas
mrna
knockdown
could
influenc
conjug
sirna
tat
penetratin
cholesterol
figur
tat
sirna
show
knockdown
time
point
although
signific
howev
though
knockdown
compar
achiev
equimolar
dose
unconjug
sirna
administr
tat
peptid
alon
produc
compar
statist
signific
knockdown
time
point
examin
suggest
cpp
modul
map
kinas
express
similarli
although
penetratinsirna
conjug
appear
show
increas
knockdown
peptid
alon
also
caus
signific
reduct
map
kinas
mrna
level
contrast
cholesterol
conjug
sirna
increas
durat
magnitud
respons
signific
reduct
map
kinas
mrna
express
seen
level
compar
achiev
nmol
dose
unconjug
sirna
highli
lipophil
natur
cholesterol
result
low
solubl
water
unabl
determin
direct
result
administr
cholesterol
lung
histolog
studi
sirna
sirnaconjug
distributionto
determin
distribut
sirna
sirnaconjug
lung
end
antisens
strand
label
fluorochrom
post
administr
histolog
analysi
show
intens
stain
macrophag
within
parenchyma
subepitheli
tissu
bronchi
bronchiol
suggest
might
repres
princip
target
cell
popul
figur
addit
observ
intens
scatter
stain
epitheli
cell
within
bronchi
bronchiol
appear
allornoth
respons
rare
posit
stain
alveolar
epitheli
cell
detect
sirna
conjug
penetratin
cholesterol
influenc
cellular
label
pattern
result
shown
howev
conjug
tat
appear
caus
small
increas
stain
intens
number
posit
cell
increas
nuclear
stain
figur
contrast
dose
equimolar
amount
dissolv
pb
produc
diffus
stain
around
larg
bronchi
blood
vessel
data
shown
examin
sirna
sirnaconjug
stabil
vivoto
determin
whether
observ
might
influenc
sirna
sirnaconjug
stabil
examin
degrad
profil
follow
exposur
mous
bal
fluid
although
bal
fluid
incub
result
appear
singl
doublestrand
cleavag
product
full
length
sirna
could
still
detect
figur
ident
stabil
cleavag
pattern
seen
tat
sirna
penetratinsirna
cholesterolsirna
impli
conjug
deliveri
moieti
signific
effect
upon
sirna
stabil
higherord
structur
observ
anneal
cholsirna
gel
capabl
improv
sirna
stabil
figur
importantli
shift
gel
mobil
appear
entir
due
sirna
cleavag
tat
penetratin
peptid
conjug
chemistri
stabl
bal
fluid
time
rang
examin
breakdown
product
use
malditof
mass
spectral
analysi
show
auidt
cleav
end
sens
strand
whilst
u
residu
cleav
end
antisens
strand
probabl
action
rnase
alik
activ
produc
blunt
end
sirna
examin
effect
sirna
cpp
sirnaconjug
upon
innat
immun
respons
vivoprevi
report
suggest
sirna
capabl
stimul
innat
immun
respons
bind
toll
like
receptor
tlr
within
endosom
elimin
possibl
observ
reduct
map
kinas
mrna
express
might
result
activ
respons
measur
level
immun
marker
whole
lung
expect
posit
control
lipopolysaccharid
lp
poli
c
known
activ
immun
respons
respect
induc
robust
increas
product
whilst
lp
increas
figur
interestingli
except
penetratinsirna
none
experiment
agent
induc
immun
respons
follow
intratrach
administr
case
penetratinsirna
observ
signific
increas
express
well
elev
releas
figur
mean
control
contamin
lp
dose
prepar
potenti
influenc
map
kinas
express
induc
immun
activ
measur
lp
content
includ
sirna
qualiti
control
process
crucial
lp
level
eu
among
prepar
significantli
concentr
believ
activ
mediat
respons
paper
investig
util
cell
penetr
peptid
tat
penetratin
lipid
carrier
cholesterol
improv
sirnamedi
knockdown
endogen
mrna
express
mous
lung
chosen
target
map
kinas
key
compon
inflammatori
signal
transduct
pathway
whose
inhibit
amelior
inflammatori
respons
constitut
express
varieti
lungassoci
cell
type
includ
epitheli
endotheli
macrophag
eosinophil
fibroblast
smooth
muscl
cell
type
quantiti
sirna
employ
investig
approxim
compar
report
efficaci
lung
thu
sirna
dose
employ
attenu
heme
oxygenas
express
dose
found
reduc
rsv
piv
titer
lung
follow
intratrach
administr
sequencespecif
sirnamedi
map
kinas
mrna
knockdown
observ
earli
impli
rapid
uptak
action
nake
sirna
upon
target
gene
mrna
level
howev
short
durat
knockdown
observ
dose
quickli
revers
within
suggest
nake
sirna
might
rapidli
degrad
action
might
extend
chemic
stabil
inde
bal
fluid
stabil
studi
show
even
though
full
length
sirna
could
still
recov
hr
cleavag
inde
occur
detect
earli
min
altern
hypothesi
might
exist
feedback
mechan
maintain
mrna
level
constitut
express
map
kinas
increas
transcript
failur
detect
vitro
could
ascrib
cell
line
use
howev
vitro
studi
allow
identif
potent
select
sirna
sequenc
insofar
util
sirna
regul
gene
express
lung
pursu
knowledg
first
report
attempt
manipul
endogen
constitut
express
gene
inde
littl
known
biochemistri
map
kinas
mrna
level
homeostasi
research
focus
phosphoryl
protein
key
part
inflammatori
signal
transduct
process
respect
observ
signific
chang
map
kinas
mrna
express
mous
lung
hr
min
challeng
mgml
aerosolis
lp
map
kinas
rel
mrna
level
salin
challeng
control
moscho
unpublish
data
therefor
either
mrna
level
either
affect
cellular
stress
signal
lpsinduc
inflamm
close
monitor
strictli
maintain
specif
level
find
appar
limit
maxim
mrna
knockdown
achiev
vivo
lend
weight
hypothesi
unabl
overcom
threshold
sinc
increas
sirna
dose
improv
durat
magnitud
respons
notwithstand
homeostasi
addit
contributor
limit
knockdown
could
uneven
lung
distribut
localis
immedi
epitheli
cell
layer
poor
cellular
uptak
therefor
examin
distribut
label
sirna
histolog
show
uptak
macrophag
scatter
airway
epitheli
cell
howev
total
tissu
mrna
downregul
compar
seen
liver
follow
intraven
administr
cholesterol
link
stabilis
sirna
improv
upon
durat
magnitud
map
kinas
mrna
knockdown
examin
effect
chemic
conjug
sirna
number
nonvir
molecular
deliveri
vector
includ
cholesterol
cell
penetr
peptid
tat
penetratin
sinc
free
hydroxyl
group
end
antisens
strand
thought
crucial
mechan
rna
interfer
deliveri
moieti
conjug
end
sens
strand
via
linker
dissoci
sens
strand
deliveri
vector
cytosol
includ
disulphid
bond
within
conjug
chemistri
believ
cleav
intracellularli
examin
biolog
action
modifi
sirna
vitro
show
conjug
linker
increas
ec
affect
maxim
level
mrna
knockdown
magnitud
efficaci
cell
cultur
similar
report
sirna
success
use
vivo
thu
ratifi
choic
conjug
chemistri
unlik
mous
studi
examin
map
kinas
knockdown
cell
show
effect
nake
sirna
concentr
contrast
cholesterol
penetratin
tat
construct
produc
small
signific
mrna
knockdown
without
induc
toxic
importantli
determin
sirnaspecif
effect
observ
equimolar
quantiti
two
unconjug
cpp
howev
uptak
mechan
appear
highli
ineffici
sinc
concentr
higher
effect
lipofectamin
surprisingli
previou
cell
base
studi
use
sirna
conjug
cholesterol
penetratin
tat
gave
valu
reportedli
submicromolar
rang
reason
differ
present
unknown
although
could
relat
gene
target
cell
type
andor
type
synthet
construct
major
investig
like
attach
deliveri
vector
end
sens
strand
via
disulphid
bond
although
chiu
et
al
attach
tat
antisens
strand
report
soutschek
et
al
cholesterol
moieti
conjug
end
sens
strand
via
pyrrolidon
linker
crucial
unlik
mani
investig
report
postconjug
hplc
purif
presenc
denatur
agent
remov
excess
unconjug
cation
cpp
cppsirna
conjug
electrostat
base
deliveri
system
cation
lipid
polym
omiss
purif
step
like
result
format
complex
excess
cpp
cppsirna
conjug
might
increas
efficaci
uptak
despit
low
potenc
conjug
cultur
proceed
vivo
investig
sinc
administr
solut
concentr
greater
effect
vitro
significantli
studi
fail
show
effect
conjug
cell
penetr
peptid
tat
penetratin
upon
either
lung
distribut
magnitud
durat
map
kinas
mrna
knockdown
strikingli
penetratin
peptid
alon
induc
signific
downregul
map
kinas
mrna
express
case
tat
also
observ
data
therefor
document
biolog
action
peptid
upon
gene
express
associ
regulatori
process
mechan
underli
respons
current
known
extent
consequ
gene
modul
enact
cpp
vivo
lack
advers
reaction
behavior
follow
peptid
administr
impli
involv
lung
toxic
form
necrosi
apoptosi
inde
associ
studi
laboratori
use
lung
epitheli
cell
line
expos
tat
penetratin
unabl
detect
toxic
concentr
altern
downregul
map
kinas
mrna
express
might
occur
follow
interact
cpp
extracellular
intracellular
target
inde
extracellular
cppprotein
interact
like
fotinmleczek
et
al
shown
tat
penetratin
induc
clathrindepend
uptak
egf
receptor
without
activ
though
exact
mechan
unknown
also
given
fact
cpp
deriv
dna
bind
domain
transcript
factor
highli
posit
charg
might
envisag
taken
cell
high
concentr
peptid
directli
interfer
gene
transcript
interestingli
highaffin
bind
cpp
plasma
membran
genom
dna
previous
shown
result
erron
conclus
mechan
cpp
uptak
interpret
find
indic
global
gene
express
perturb
cpp
restrict
lack
effect
cpp
express
vitro
even
concentr
high
term
direct
effect
cpp
regul
gene
express
lack
specif
effect
locu
mean
cppdna
interact
postul
assumpt
signific
sequenc
differ
exist
genom
balbc
mice
use
vivo
experi
cell
line
deriv
instead
like
scenario
would
favor
cpp
target
signal
transduct
pathway
transcript
regul
gene
express
altern
viral
origin
cpp
coupl
intern
cytokin
receptor
might
expect
activ
antivir
innat
respons
result
inhibit
transcript
howev
mechan
would
appear
unlik
associ
proinflammatori
marker
releas
vivo
detect
investig
immunolog
respons
vivo
show
penetratinsirna
tat
cholesterol
conjug
administr
induc
innat
immun
respons
possibl
activ
andor
liposom
deliveri
sirna
contain
immunostimulatori
sequenc
shown
necessari
activ
tolllik
receptor
underscor
import
uptak
mechan
tlr
mediat
immun
activ
sirna
significantli
none
current
known
immunostimulatori
sirna
motif
found
sirna
sequenc
administ
moscho
contrast
cpp
although
cholesterol
conjug
fail
increas
magnitud
map
kinas
knockdown
extend
durat
mrna
knockdown
howev
although
gel
electrophoresi
indic
format
higher
molecular
weight
complex
cholesterol
sirna
conjug
improv
upon
sirna
stabil
bal
fluid
found
improv
upon
lung
distribut
accord
histolog
investig
overal
studi
demonstr
sirna
mediat
knockdown
endogen
constitut
express
gene
map
kinas
mous
lung
although
cholesterol
increas
durat
knockdown
fact
magnitud
respons
unaffect
follow
conjug
cholesterol
tat
penetratin
suggest
either
cpp
unabl
increas
cellular
deliveri
distribut
altern
circumst
maxim
respons
achiev
nake
sirna
alon
howev
sinc
tat
penetratin
alon
induc
chang
gene
express
believ
despit
widespread
success
cpp
deliveri
biolog
activ
peptid
protein
vivo
result
highlight
need
continu
elucid
mechan
cpp
bioactiv
order
determin
applic
deliveri
biopharmaceut
content
support
find
penetratinsirna
tat
sirna
conjug
caus
activ
innat
immun
respons
impli
differ
intracellular
fate
refer
web
version
pubm
central
supplementari
materi
stabil
map
kinas
sirna
sirna
conjug
cell
penetr
peptid
tat
b
penetratin
c
well
cholesterol
mous
lung
bronchoalveolar
lavag
fluid
sirna
construct
incub
vv
mous
lung
bal
fluid
indic
time
pmol
quantiti
analys
tbe
page
use
sybrgold
stain
intratrach
administr
singl
nmol
dose
cell
penetr
peptid
tat
tat
penetratin
pen
map
kinas
sirna
sirna
conjug
sirna
tat
tatsirna
cholesterol
cholsirna
penetratinsirna
conjug
pensirna
elicit
inflammatori
cytokin
releas
murin
lung
tissu
mice
dose
halothan
anaesthesia
pb
volum
lung
remov
protein
extract
interferon
tumour
necrosi
factor
interleukin
content
determin
sandwich
elisa
express
pgml
per
mg
total
protein
p
versu
pb
treat
control
nd
determin
due
lack
sampl
